Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Hudson Executive Investment (HEC) Competitors

Hudson Executive Investment logo

HEC vs. KDLY, BTTX, UPHL, OMI, ATXS, CYH, SY, SMLR, KMDA, and LXRX

Should you be buying Hudson Executive Investment stock or one of its competitors? The main competitors of Hudson Executive Investment include Kindly MD (KDLY), Better Therapeutics (BTTX), UpHealth (UPHL), Owens & Minor (OMI), Astria Therapeutics (ATXS), Community Health Systems (CYH), So-Young International (SY), Semler Scientific (SMLR), Kamada (KMDA), and Lexicon Pharmaceuticals (LXRX). These companies are all part of the "medical" sector.

Hudson Executive Investment vs. Its Competitors

Kindly MD (NASDAQ:KDLY) and Hudson Executive Investment (NASDAQ:HEC) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

In the previous week, Kindly MD had 2 more articles in the media than Hudson Executive Investment. MarketBeat recorded 2 mentions for Kindly MD and 0 mentions for Hudson Executive Investment. Kindly MD's average media sentiment score of 0.81 beat Hudson Executive Investment's score of 0.00 indicating that Kindly MD is being referred to more favorably in the media.

Company Overall Sentiment
Kindly MD Positive
Hudson Executive Investment Neutral

Kindly MD has higher revenue and earnings than Hudson Executive Investment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kindly MD$2.47M6.78-$4.64M-$0.77-3.61
Hudson Executive InvestmentN/AN/A-$27.24MN/AN/A

73.4% of Hudson Executive Investment shares are held by institutional investors. 50.5% of Kindly MD shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Kindly MD's return on equity of 0.00% beat Hudson Executive Investment's return on equity.

Company Net Margins Return on Equity Return on Assets
Kindly MDN/A N/A N/A
Hudson Executive Investment N/A -337.48%-4.06%

Summary

Kindly MD beats Hudson Executive Investment on 7 of the 8 factors compared between the two stocks.

Get Hudson Executive Investment News Delivered to You Automatically

Sign up to receive the latest news and ratings for HEC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HEC vs. The Competition

MetricHudson Executive InvestmentHealth Services IndustryMedical SectorNASDAQ Exchange
Market Cap$105.98M$76.68M$5.85B$10.14B
Dividend YieldN/AN/A5.68%4.60%
P/E RatioN/AN/A75.3425.98
Price / SalesN/A3.05514.97181.19
Price / CashN/A4.0237.5660.44
Price / Book21.331.1512.156.29
Net Income-$27.24M-$26.33M$3.29B$271.07M

Hudson Executive Investment Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HEC
Hudson Executive Investment
N/A$2.56
-1.5%
N/A+43.6%$105.98MN/A0.00N/A
KDLY
Kindly MD
N/A$8.08
+77.2%
N/A+218.1%$48.66M$2.47M-10.49N/AGap Down
High Trading Volume
BTTX
Better Therapeutics
N/A$0.00
flat
N/AN/A$5KN/A0.0040
UPHL
UpHealth
N/A$0.00
flat
N/A-99.9%$4K$130M0.001,750High Trading Volume
OMI
Owens & Minor
4.7194 of 5 stars
$5.48
-1.0%
$7.63
+39.3%
-63.2%$427.16M$10.70B-0.3523,200Positive News
Short Interest ↑
ATXS
Astria Therapeutics
3.0202 of 5 stars
$7.49
-0.5%
$29.00
+287.2%
-30.0%$424.95MN/A-3.7330Positive News
CYH
Community Health Systems
3.9247 of 5 stars
$2.93
-2.5%
$3.58
+22.2%
-47.6%$420.36M$12.63B-1.9660,000Positive News
SY
So-Young International
2.4582 of 5 stars
$3.67
-11.4%
$5.50
+49.9%
-69.3%$416.18M$200.94M-4.221,800Positive News
SMLR
Semler Scientific
2.9958 of 5 stars
$28.02
-0.2%
$81.75
+191.8%
+18.7%$415.57M$56.29M11.53120News Coverage
KMDA
Kamada
4.4728 of 5 stars
$7.14
-0.1%
$13.00
+82.1%
+29.5%$411.16M$160.95M21.00360Short Interest ↓
LXRX
Lexicon Pharmaceuticals
2.2086 of 5 stars
$1.08
-4.4%
$3.23
+198.6%
-31.1%$410.64M$31.08M-3.27140News Coverage

Related Companies and Tools


This page (NASDAQ:HEC) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners